Publication | Closed Access

High serum levels of IL-2R, IL-6, and TNF-α are associated with higher tumor burden and poorer outcome of follicular lymphoma patients in the rituximab era

Hematological MalignancyLymphoid NeoplasiaCancer ImmunosurveillanceFollicular Lymphoma PatientsMedicineImmunodeficienciesImmunologyHematologyPathologyImmune RegulationImmune SurveillanceHigh Serum LevelsRituximab EraImmunotherapyOncologyCancer Research